dopamine
Reaction #1858
(S)-(-)-nicotine
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-1998_03
Reaction #2817
(S)-(-)-nicotine
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-1998_03
Reaction #5022
(S)-(-)-nicotine
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-1993_09
Reaction #6467
(S)-(-)-nicotine
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-1993_09
Reaction #11492
(−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane HCl
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2006_08
Reaction #42984
N-(3-Amino-propyl)-N-(3-{2-[2-(3,4-dihydroxy-phenyl)-ethylamino]-pyrimidin-4-yl}-benzyl)-methanesulfonamide
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2010_06
Reaction #80685
(S)-(-)-nicotine
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-1997_04
Reaction #190736
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (2/10)
Reaction #245265
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (9/10)
Reaction #246591
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (9/10)
Reaction #322444
(S)-(-)-nicotine
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-1997_01
Reaction #336467
(S)-(-)-nicotine
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-1993_05
Reaction #379086
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (8/10)
Reaction #381469
DOI: 10.1039/C8SC04228DTraining data from https://doi.org/10.1039/C8SC04228D (8/10)
Reaction #482013
(S)-(−)-nicotine
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2003_08
Reaction #486949
(S)-(-)-nicotine
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-1998_10
Reaction #500956
(−)-1-(3,4-Dichlorophenyl)-3-azabicyclo[3.1.0]hexane HCl
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2003_05
Reaction #534889
morphine
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_07
Reaction #535366
N-trans-feruloyldopamine
DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_07
Reaction #539521
levodopa
Ausbeute 458.9%DOI: 10.6084/m9.figshare.5104873.v1uspto-grants-2013_07
Seite 1Weiter